Growth Metrics

Armata Pharmaceuticals (ARMP) Capital Expenditures (2016 - 2026)

Quarterly results put Capital Expenditures at $63000.0 for Q1 2026, down 36.36% from a year ago — trailing twelve months through Mar 2026 was $506000.0 (down 70.72% YoY), and the annual figure for FY2025 was $542000.0, down 71.15%.

Armata Pharmaceuticals has reported Capital Expenditures over the past 14 years, most recently at $63000.0 for Q1 2026.

  • Capital Expenditures reached $63000.0 in Q1 2026 per ARMP's latest filing, up from $52000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $3.5 million in Q3 2023 and bottomed at -$455000.0 in Q4 2022.
  • Median Capital Expenditures over the past 5 years was $242000.0 (2025), compared with a mean of $755235.3.
  • The largest annual shift saw Capital Expenditures crashed 299.56% in 2022 before it soared 751.69% in 2023.
  • Over 5 years, Capital Expenditures stood at -$455000.0 in 2022, then soared by 627.47% to $2.4 million in 2023, then plummeted by 103.21% to -$77000.0 in 2024, then skyrocketed by 167.53% to $52000.0 in 2025, then rose by 21.15% to $63000.0 in 2026.
  • Business Quant data shows Capital Expenditures for ARMP at $63000.0 in Q1 2026, $52000.0 in Q4 2025, and $242000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 133.40 Mn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 230.60 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 21.83 Mn
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn - 63,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 63,000.00
Mar 31, 2026 63,000.00
Dec 31, 2025 52,000.00
Dec 31, 2025 52,000.00
Sep 30, 2025 242,000.00
Sep 30, 2025 242,000.00
Jun 30, 2025 149,000.00
Jun 30, 2025 149,000.00
Mar 31, 2025 99,000.00
Mar 31, 2025 99,000.00
Dec 31, 2024 -77,000.00
Dec 31, 2024 -77,000.00
Sep 30, 2024 340,000.00
Sep 30, 2024 340,000.00
Jun 30, 2024 1.37 Mn
Jun 30, 2024 1.37 Mn
Mar 31, 2024 250,000.00
Mar 31, 2024 250,000.00
Dec 31, 2023 2.40 Mn
Dec 31, 2023 2.40 Mn
Sep 30, 2023 3.51 Mn
Sep 30, 2023 3.51 Mn
Jun 30, 2023 222,000.00
Jun 30, 2023 222,000.00
Mar 31, 2023 2.01 Mn
Mar 31, 2023 2.01 Mn
Dec 31, 2022 -455,000.00
Dec 31, 2022 -455,000.00
Sep 30, 2022 1.29 Mn
Sep 30, 2022 1.29 Mn
Jun 30, 2022 1.14 Mn
Jun 30, 2022 1.14 Mn
Mar 31, 2022 236,000.00
Mar 31, 2022 236,000.00
Dec 31, 2021 228,000.00
Dec 31, 2021 228,000.00
Sep 30, 2021 582,000.00
Sep 30, 2021 582,000.00
Jun 30, 2021 196,000.00
Jun 30, 2021 196,000.00
Mar 31, 2021 298,000.00
Mar 31, 2021 298,000.00
Dec 31, 2020 366,000.00
Dec 31, 2020 366,000.00
Sep 30, 2020 81,000.00
Sep 30, 2020 81,000.00
Jun 30, 2020 273,000.00
Jun 30, 2020 273,000.00
Mar 31, 2020 104,000.00
Mar 31, 2020 104,000.00
Dec 31, 2019 21,000.00
Dec 31, 2019 21,000.00
Sep 30, 2019 -65,000.00
Sep 30, 2019 -65,000.00
Jun 30, 2019 126,000.00
Jun 30, 2019 126,000.00
Mar 31, 2019 142,000.00
Mar 31, 2019 142,000.00
Dec 31, 2018 391,000.00
Dec 31, 2018 391,000.00
Sep 30, 2018 155,000.00
Sep 30, 2018 155,000.00
Dec 31, 2017 18,000.00
Dec 31, 2017 18,000.00
Sep 30, 2017 33,000.00
Sep 30, 2017 33,000.00
Jun 30, 2017 2,000.00
Jun 30, 2017 2,000.00
Mar 31, 2017 5,000.00
Mar 31, 2017 5,000.00
Dec 31, 2016 13,000.00
Dec 31, 2016 13,000.00
Sep 30, 2016 29,000.00
Sep 30, 2016 29,000.00
Jun 30, 2016 125,000.00
Jun 30, 2016 125,000.00